So! What's aging? Is cardiovascular aging a disease?

Journal of Molecular and Cellular Cardiology

Volumn 83, Issue , 2015, Pages 1-13

  Lakatta, Edward G ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; CONTRACTILE PROTEIN;

AGING; ARTERITIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; ENERGY METABOLISM; ENVIRONMENTAL PROTECTION; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE; HUMAN; HYPERTENSION; INFLAMMATION; LIFE EXPECTANCY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; REST; SIGNAL TRANSDUCTION; VASCULAR REMODELING; ANIMAL; ARTERY; CARDIAC MUSCLE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; MALE; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PROTEIN PROCESSING; VASCULAR SMOOTH MUSCLE;

ORYCTOLAGUS CUNICULUS; PRIMATES; RATTUS;

AGING; ANIMALS; ARTERIES; CARDIOVASCULAR DISEASES; CONTRACTILE PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE-ENVIRONMENT INTERACTION; HUMANS; INFLAMMATION; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; OXIDATION-REDUCTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84937979119     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.04.005     Document Type: Article

References (69)

1. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a "set up" for vascular disease. Circulation 2003, 107:139-146.
2. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., et al. Heart disease and stroke statistics-2010 update. A report from the American Heart Association. Circulation 2010, 121:e1-e170.
3. Upadhya B., Taffet G.E., Cheng C.P., Kitzman D.W. Heart failure with preserved ejection fraction in the elderly: scope of the problem. J Mol Cell Cardiol 2015, 83:73-87.
4. The World Health Report 1997-conquering, suffering, enriching humanity 1997, World Health Organization, Geneva.
5. Kirkwood T.B. A systematic look at an old problem. Nature Feb 7 2008, 451(7179):644-647.
6. AlGhatrif M., Lakatta E.G. The reality of aging viewed from the arterial wall. Chapter in blood pressure and arterial wall mechanics in cardiovascular diseases 2014, 137-154. Springer, London. M.E. Safar, M.F. O'Rourke, E.D. Frohlich (Eds.).
7. Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003, 107:490-497.
8. Wang M., Lakatta E.G. Central arterial aging: humans to molecules. Handbook of hypertension: arterial stiffness in hypertension 2006, 9:137-160. Elsevier. M. Safar (Ed.).
9. Harvey A., Montezano A.C., Touyz R.M. Vascular biology of aging - implications in hypertension. J Mol Cell Cardiol 2015, 83:112-121.
10. Lakatta E.G. The reality of aging viewed from the arterial wall. Artery Res 2013, 7:73-80.
11. Wang M., Shah A. Age-associated pro-inflammatory remodeling in the heart and large arteries. J Mol Cell Cardiol 2015, 83:101-111.
12. Illi B., Ciarapica R., Capogrossi M. Chromatin methylation and cardiovascular aging. J Mol Cell Cardiol 2015, 83:21-31.
13. Ferguson B.S., McKinsey T. Non-sirtuin histone deacetylases in the control of cardiac aging. J Mol Cell Cardiol 2015, 83:14-20.
14. Greco S., Gorospe M., Martelli F. Non-coding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol 2015, 83:142-155.
15. Martin G.M. Epigenetic gambling and epigenetic drift as an antagonistic pleiotropic mechanism of aging. Aging Cell 2009, 8:761-764.
16. Martin G.M. Stochastic modulations of the pace and patterns of ageing: impacts on quasi-stochastic distributions of multiple geriatric pathologies. Mech Ageing Dev 2012, 133:107-111.
17. Hariharan N., Sussman M.A. Cardiac aging - getting to the stem of the problem. J Mol Cell Cardiol 2015, 83:32-36.
18. Linton P.J., Gurney M., Sengstock D., Mentzer R.M., Gottlieb R.A. This old heart: cardiac aging and autophagy. J Mol Cell Cardiol 2015, 83:44-54.
19. Martin G.M. Modalities of gene action predicted by the classical evolutionary biological theory of aging. Ann N Y Acad Sci 2007, 1100:14-20.
20. Cannon W.B. Organization for physiological homeostasis. Physiol Rev 1929, 9:399-431.
21. Seeman T.B., Singer B.H., Rowe J.W., Horwitz R.I., McEwen B.S. Price of adaptation - allostatic load and its health consequences: MacArthur studies of successful aging. Arch Intern Med 1997, 157:2259-2268.
22. Sterling P. Principles of allostasis: optimal design, predictive regulation, pathophysiology and rational therapeutics. Allostasis, homeostasis, and the costs of adaptation 2004, Cambridge University Press, Cambridge. J. Schulkin (Ed.).
23. Shock N.W. Physiological aspects of aging in man. Annu Rev Physiol 1961, 23:97-122.
24. CIBA Foundation Symposium. Research and the ageing population 1988, John Wiley & Sons Ltd., Chichester UK.
25. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part II: the aging heart in health: links to heart disease. Circulation 2003, 107:346-354.
26. Lakatta E.G., Schulman S.P., Gerstenblith G. Cardiovascular aging in health and therapeutic considerations with respect to cardiovascular disease in older patients. Hurst's The Heart 2001, 86:2329-2355. McGraw-Hill, [Chapter]. V. Fuster, R.W. Alexander, R.A. O'Rourke (Eds.).
27. Wang M., Jiang L., Monticone R.E., Lakatta E.G. Proinflammation: the key to arterial aging. Trends Endocrinol Metab 2014, 25:72-79.
28. Donato A.J., Morgan R.G., Walker A.E., Lesniewski L.A. Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol 2015, [in press].
29. Lopez-Ilasaca M., Liu X., Tamura K., Dzau V.J. The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling. Mol Biol Cell 2003, 14(12):5038-5050.
30. Min L.J., Mogi M., Tamura K., Iwanami J., Sakata A., Fujita T., et al. Angiotensin II type 1 receptor-associated protein prevents vascular smooth muscle cell senescence via inactivation of calcineurin/nuclear factor of activated T cells pathway. J Mol Cell Cardiol 2009, 47(6):798-809.
31. de Cavanagh E.M.V., Inserra F., Ferder L. Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?. Cardiovasc Res 2011, 89(1):31-40.
32. Cencioni C., Spallotta F., Mai A., Martelli F., Farsetti A., Zeiher A.M., et al. Sirtuin function in aging hearts and vessels. J Mol Cell Cardiol 2015, 83:55-61.
33. Biala A.K., Kirshenbaum L.A. Mitochondrial dynamics: orchestrating the journey to advanced age. J Mol Cell Cardiol 2015, 83:37-43.
34. Wang M., Zhang J., Spinetti G., Monticone R., Zhao D., Cheng L., et al. Angiotensin II activates metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am J Pathol 2005, 167:1429-1442.
35. 1 receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders. Cell Mol Neurobiol 2012, 32:667-681.
36. Michel J.B., Heudes D., Michel O., Poitevin P., Philippe M., Scalbert E., et al. Effect of chronic Ang I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol Jul 1994, 267(1 Pt 2):R124-R135.
37. Basso N., Cini R., Pietrelli A., Ferder L., Terragno N.A., Inserra F. Protective effect of long-term angiotensin II inhibition. Am J Physiol Heart Circ Physiol 2007, 293(3):H1351-H1358.
38. Benigni A., Corna D., Zoja C., Sonzogni A., Latini R., Salio M., et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 2009, 119:524-530.
39. Linz W., Heitsch H., Scholkens B.A., Wiemer G. Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats. Hypertension 2000, 35:908-913.
40. Yu B.P., Masoro E.G., McMahan C.A. Nutritional influences on aging of Fischer 344 rats: I. Physical, metabolic, and longevity characteristics. J Gerontol 1985, 40:657-670.
41. Thompson R.C., Allam A.H., Lombardi G.P., Wann L.S., Sutherland M.L., Sutherland J.D., et al. Atherosclerosis across 4000years of human history: the Horus study of four ancient populations. Lancet Apr 6 2013, 381(9873):1211-1222.
42. Brodde O.E., Knoschak U., Becker K., Ruter F., Poller U., Jakubetz J., et al. Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies. J Clin Invest 1998, 101:471.
43. Lakatta E.G. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993, 73:413.
44. Najjar S.S., Lakatta E.G., Gerstenblith G. Cardiovascular aging: the next frontier in cardiovascular prevention. Prevention of cardiovascular disease: companion to Braunwald's heart disease 2011, 415-432. Saunders, Philadelphia. R. Blumenthal, J. Foody, N.A. Wong (Eds.).
45. 2+ signaling. Am J Physiol Heart Circ Physiol 2014, 306:H1385-H1397.
46. Monfredi O., Boyett M.R. Sick sinus syndrome and atrial fibrillation in older persons-a view from the sinoatrial nodal myocyte. J Mol Cell Cardiol 2015, 83:88-100.
47. Fendooni H.A., Dibb K.M., Howlett S.E. How cardiomyocyte excitation, calcium release and contraction become altered with age. J Mol Cell Cardiol 2015, 83:62-72.
48. Najjar S.S., Schulman S.P., Gerstenblith G., Fleg J.L., Kass D.A., O'Connor F., et al. Age and gender affect ventricular-vascular coupling during aerobic exercise. J Am Coll Cardiol 2004, l44:611-617.
49. Yin F.C., Weisfeldt M.L., Milnor W.R. Role of aortic input impedance in the decreased cardiovascular response to exercise with aging in dogs. J Clin Invest 1981, 68(1):28-38.
50. Meerson F.Z., Javich M.P., Lerman M.I. Decrease in the rate of RNA and protein synthesis and degradation in the myocardium under long-term compensatory hyperfunction and on aging. J Mol Cell Cardiol 1978, 10:145-159.
51. Lakatta E.G. Regulation of cardiac muscle function in the hypertensive heart. Cellular and molecular mechanisms of hypertension 1991, 149-173. Plenum, New York. R.H. Cox (Ed.).
52. Boluyt M.O., Lakatta E.G. Cardiovascular aging in health. Heart metabolism in failure 1998, vol. 4B:257-303. JAI Press Inc. R.A. Altschuld, R.A. Haworth (Eds.).
53. Baker K.M., Chernin M.I., Wixson S.K., Aceto J.F. Renin angiotensin system involvement in pressure overload cardiac hypertrophy in rats. Am J Physiol 1990, 259:H324-H332.
54. Zhang X., Dostal D.E., Reiss K., Cheng W., Kajstura J., Li P., et al. Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes. Am J Physiol 1995, 269:H1791-H1802.
55. Heymes C., Swynghedauw B., Chevalier B. Activation of angiotensinogen and angiotensin-converting enzyme gene expression in the left ventricle of senescent rats. Circulation 1994, 90:1328-1332.
56. Sadoshima J., Xu Y., Slayter H.S., lzumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993, 75:977-984.
57. Schunkert H., Dzau V., Tang S., Hirsch A., Apstein C., Lorell B. Increased rat cardiac angiotensin-converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest 1990, 86:1913-1920.
58. Makino N., Hata T., Sugano M., Dixon I.M.C., Yanaga T. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type-1 receptor in rats. J Mol Cell Cardiol 1996, 28:507-517.
59. Reaven E.P., Reaven G.M. Structure and function changes in the endocrine pancreas of aging rats with reference to the modulating effects of exercise and caloric restrictions. J Clin Invest 1981, 68:75-84.
60. Peng M.T., Kang M. Circadian rhythms and patterns of running-wheel activity, feeding and drinking behaviors of old rats. Physiol Behav 1984, 33:615-620.
61. Spurgeon H.A., Steinbach M.F., Lakatta E.G. Chronic exercise prevents characteristic age-related changes in rat cardiac contraction. Am J Physiol 1983, 244:H513-H518.
62. Lakatta E.G., Spurgeon H.A. Effect of exercise on cardiac muscle performance in aged rats. FASEB 1987, 46:1844-1849.
63. Komatsu M., lsoyama S., Takishima T. Effects of aging on induction of cardiocyte growth by extracardiac factors. Am J Physiol 1994, 266:H2279-H2286.
64. Udelsman R., Li D., Stagg C., Holbrook N. Aortic crosstransplantation between young and old rats: effect upon the heat shock protein 70 stress response. J Gerontol Biol Sci 1995, 50A:B187-B192.
65. Seals D.R., Justice J.N., LaRocca T.J. Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity. J Physiol Jan 29 2015, [Epub ahead of print]. 10.1113/jphysiol.2014.282665.
66. Kwak H.B. Aging, exercise, and extracellular matrix in the heart. J Exerc Rehabil 2013, 9:338-347.
67. Vigorito C., Giallauria F. Effects of exercise on cardiovascular performance in the elderly. Front Physiol 2014, 5:51.
68. Corbi G., Conti V., Russomanno G., Rengo G., Vitulli P., Ciccarelli A.L., et al. Is physical activity able to modify oxidative damage in cardiovascular aging?. Oxid Med Cell Longev 2012, 2012:728547.
69. Santos-Parker J.R., LaRocca T.J., Seals D.R. Aerobic exercise and other healthy lifestyle factors that influence vascular aging. Adv Physiol Educ 2014, 38:296-307.